COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
Details
Serval ID
serval:BIB_0C812855490A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
Journal
The Pediatric infectious disease journal
Working group(s)
Swissped RECOVERY Trial Group
Contributor(s)
Koehler H., Gysi S., Janz I., Bieri A., Donner B., Hammer J., Heininger U., von Kalckreuth C., Kohns M., Mettauer N., Meyer A., Reppucci D., Schlaeppi C., Trachsel D., Vaezipour N., Woerner A., Zutter A., Vanoni F., Kottanattu L., Mazzara C., Severi Conti A., Aebi C., Agyeman P., Duppenthaler A., Glöckler M., Pallivathukal S., Riedel T., Zimmermann P., Cudré-Cung H.P., Pavlovic M., Bordessoule A., Martin A.L., Polito A., Wagner N., Rohr M., L'Huillier A., Amiet V., Ferry T., Longchamp D., Natterer J., Oppenheim R., Hofer M., Buettcher M., Wechselberger K., Donas A., Germann S., Lütolf Erni M., Kaiser D., Schwendener Scholl K., Peter Kuen H., Hrup K., Stritt J., Bailey DGN, Wachinger T., Beck I., Birkenmaier A., Rogdo B., Lorenz P., Iglowstein I., Zöhrer K., Flade M., Prader S., Pachlopnik Schmid J., Seiler M., Meyer Sauteur P., Brotschi B., Weber K., Whittaker E., Faust S.N.
ISSN
1532-0987 (Electronic)
ISSN-L
0891-3668
Publication state
Published
Issued date
01/04/2024
Peer-reviewed
Oui
Volume
43
Number
4
Pages
361-364
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.
Pubmed
Open Access
Yes
Create date
26/01/2024 14:46
Last modification date
12/03/2024 8:08
Usage data
